Table of Contents

November 01, 2021; Volume 18,Issue 4

  1. Bai, Rilan

    1. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

  2. Bai, Xueli

    1. Multiplex imaging reveals the architecture of the tumor immune microenvironment
      Junlei Zhang, Jinyuan Song, Jianpeng Sheng, Xueli Bai and Tingbo Liang
      Cancer Biology & Medicine November 2021, 18 (4) 949-954; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0494

  3. Chen, Fengyang

    1. Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027

  4. Chen, Huijing

    1. Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022

  5. Chen, Naifei

    1. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

  6. Chen, Xiao

    1. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

  7. Chen, Xiaobing

    1. Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
      Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian and He Ren
      Cancer Biology & Medicine November 2021, 18 (4) 937-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0406

  8. Chen, Xin

    1. Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027

  9. Chen, Yu

    1. Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022

  10. Cui, Jiuwei

    1. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052
« Previous (Pages : 1 2 3 4 5 6 ... 13) Next »
Back to top

In this issue

Cancer Biology & Medicine: 18 (4)
Cancer Biology & Medicine
Vol. 18, Issue 4
1 Nov 2021

Submit

Sign up for alerts